LMAT - LeMaitre regains European CE marking for five products

Under the European Medical Devices Directive (93/42/EC as amended by 2007/47/EC), LeMaitre Vascular ([[LMAT]] +0.7%) has received CE marks for five products that had previously lapsed due to a change in notified bodies, the company announced.Due to the transition, the company lost CE marks on several products that accounted for less than 3% of its 2019 Europe/Middle East/Africa ((EMEA)) sales, Andrew Hodgkinson, SVP of LeMaitre’s Clinical, Regulatory & Quality Affairs, said.“We are pleased to have received these five CE marks before the transition to the new Medical Device Regulation in the EU on May 26, 2021,” he added.EMEA sales at LeMaitre dropped ~5% YoY making up only ~27% of the company’s net sales in Q1 2021 down from ~34% in the prior-year quarter.

For further details see:

LeMaitre regains European CE marking for five products